These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 31859768)

  • 21. Appropriateness of Broad Spectrum Antibiotics for Severe Sepsis and Septic Shock in the Emergency Department.
    Worapratya P; Joraluck J; Wanjaroenchaisuk A; Wuthisuthimethawee P
    J Med Assoc Thai; 2016 May; 99(5):477-83. PubMed ID: 27501600
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pediatric extended spectrum β-lactamase infection: Community-acquired infection and treatment options.
    Sethaphanich N; Santanirand P; Rattanasiri S; Techasaensiri C; Chaisavaneeyakorn S; Apiwattanakul N
    Pediatr Int; 2016 May; 58(5):338-46. PubMed ID: 26513341
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical Situations of Bacteriology and Prognosis in Patients with Urosepsis.
    Jiang Y; Li J; Zhang Y; Hu X; Zhang X; Shang X; Gong S; Yu R
    Biomed Res Int; 2019; 2019():3080827. PubMed ID: 30881985
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The epidemiology of sepsis in Colombia: a prospective multicenter cohort study in ten university hospitals.
    Rodríguez F; Barrera L; De La Rosa G; Dennis R; Dueñas C; Granados M; Londoño D; Molina F; Ortiz G; Jaimes F
    Crit Care Med; 2011 Jul; 39(7):1675-82. PubMed ID: 21685740
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Incidence, risk factors, and outcome of severe sepsis and septic shock in adults. A multicenter prospective study in intensive care units. French ICU Group for Severe Sepsis.
    Brun-Buisson C; Doyon F; Carlet J; Dellamonica P; Gouin F; Lepoutre A; Mercier JC; Offenstadt G; Régnier B
    JAMA; 1995 Sep; 274(12):968-74. PubMed ID: 7674528
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Infections due to Escherichia coli producing extended-spectrum beta-lactamase among hospitalised patients: factors influencing mortality.
    Peña C; Gudiol C; Calatayud L; Tubau F; Domínguez MA; Pujol M; Ariza J; Gudiol F
    J Hosp Infect; 2008 Feb; 68(2):116-22. PubMed ID: 18226420
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Emergence of extended-spectrum β-lactamase-producing escherichia coli as a cause of community-onset bacteremia in South Korea: risk factors and clinical outcomes.
    Park SH; Choi SM; Lee DG; Kim J; Choi JH; Kim SH; Kwon JC; Yoo JH
    Microb Drug Resist; 2011 Dec; 17(4):537-44. PubMed ID: 21875342
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Associated factors and clinical outcomes of bloodstream infection due to extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae during febrile neutropenia.
    Ben-Chetrit E; Eldaim MA; Bar-Meir M; Dodin M; Katz DE
    Int J Antimicrob Agents; 2019 Apr; 53(4):423-428. PubMed ID: 30572008
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Randomized controlled trial of piperacillin-tazobactam, cefepime and ertapenem for the treatment of urinary tract infection caused by extended-spectrum beta-lactamase-producing Escherichia coli.
    Seo YB; Lee J; Kim YK; Lee SS; Lee JA; Kim HY; Uh Y; Kim HS; Song W
    BMC Infect Dis; 2017 Jun; 17(1):404. PubMed ID: 28592240
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Extended spectrum beta lactamase producing organisms causing urinary tract infections in Sri Lanka and their antibiotic susceptibility pattern -A hospital based cross sectional study.
    Fernando MM; Luke WA; Miththinda JK; Wickramasinghe RD; Sebastiampillai BS; Gunathilake MP; Silva FH; Premaratna R
    BMC Infect Dis; 2017 Feb; 17(1):138. PubMed ID: 28187754
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical management for patients admitted to a critical care unit with severe sepsis or septic shock.
    Cheung WK; Chau LS; Mak II; Wong MY; Wong SL; Tiwari AF
    Intensive Crit Care Nurs; 2015 Dec; 31(6):359-65. PubMed ID: 26292920
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical characteristics and outcome of critically ill patients with bacteremia caused by extended-spectrum β-lactamase-producing and non-producing Escherichia coli.
    Haruki Y; Hagiya H; Haruki M; Sugiyama T
    J Infect Chemother; 2018 Nov; 24(11):944-947. PubMed ID: 29803763
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Blood cultures in the emergency department].
    Cisneros-Herreros JM; Sánchez-González M; Prados-Blanco MT; Llanos-Rodríguez C; Vigil-Martín E; Soto-Espinosa de los Monteros B; Pachón-Díaza J
    Enferm Infecc Microbiol Clin; 2005 Mar; 23(3):135-9. PubMed ID: 15757584
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nitrofurantoin in the treatment of extended-spectrum β-lactamase-producing Escherichia coli-related lower urinary tract infection.
    Tasbakan MI; Pullukcu H; Sipahi OR; Yamazhan T; Ulusoy S
    Int J Antimicrob Agents; 2012 Dec; 40(6):554-6. PubMed ID: 23063743
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Prevalence and risk factors for extended-spectrum β-lactamase-producing Escherichia coli causing community-onset urinary tract infections in Colombia].
    Blanco VM; Maya JJ; Correa A; Perenguez M; Muñoz JS; Motoa G; Pallares CJ; Rosso F; Matta L; Celis Y; Garzon M; Villegas MV
    Enferm Infecc Microbiol Clin; 2016 Nov; 34(9):559-565. PubMed ID: 26774256
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical Features, Short-Term Mortality, and Prognostic Risk Factors of Septic Patients Admitted to Internal Medicine Units: Results of an Italian Multicenter Prospective Study.
    Mazzone A; Dentali F; La Regina M; Foglia E; Gambacorta M; Garagiola E; Bonardi G; Clerici P; Concia E; Colombo F; Campanini M
    Medicine (Baltimore); 2016 Jan; 95(4):e2124. PubMed ID: 26825876
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of Risk Factors, Antimicrobial Resistance Trends and Occurrence of blaTEM, bla SHV and blaCTX M in Escherichia coli Causing Bacteremia.
    Sinha R; Kamath S; M Shenoy S
    Infect Disord Drug Targets; 2016; 16(2):95-100. PubMed ID: 26707079
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Risk factors for gastrointestinal colonization by ESBL-producing Klebsiella pneumoniae and Escherichia coli in anaesthesiology and reanimation intensive care unit].
    Oğuz Mızrakçı S; Arda B; Erdem HA; Uyar M; Tünger A; Sipahi OR; Ulusoy S
    Mikrobiyol Bul; 2013 Apr; 47(2):223-9. PubMed ID: 23621722
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Correlation between in vitro bacterial growth velocity of blood of patients with clinical parameters and prognosis in patients with Escherichia coli bacteremia].
    Bo SN; Ning YZ; Zhu X; Yao GQ
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2010 Sep; 22(9):533-6. PubMed ID: 20854732
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Risk factors and prognosis in 31 patients with extended-spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae bloodstream infection].
    Chen YH; Yao WZ; Wu R; Zhou QT; Liu ZY; Zhang XW
    Zhonghua Jie He He Hu Xi Za Zhi; 2008 Nov; 31(11):815-9. PubMed ID: 19080534
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.